S&P 500   3,329.64 (+0.00%)
DOW   29,335.00 (-0.04%)
QQQ   223.70 (+0.14%)
FB   221.46 (-0.31%)
MSFT   167.75 (+0.39%)
GOOGL   1,483.25 (+0.25%)
AMZN   1,870.54 (+0.31%)
CGC   24.52 (-1.49%)
NVDA   248.94 (-0.14%)
BABA   221.92 (-2.42%)
MU   58.64 (+1.70%)
GE   11.73 (-0.76%)
TSLA   542.98 (+6.36%)
AMD   51.20 (+0.53%)
T   38.53 (+0.39%)
ACB   2.04 (-4.23%)
F   9.18 (+0.22%)
NFLX   336.41 (-0.96%)
BAC   34.52 (-0.58%)
GILD   62.78 (-0.32%)
DIS   143.83 (-0.35%)
S&P 500   3,329.64 (+0.00%)
DOW   29,335.00 (-0.04%)
QQQ   223.70 (+0.14%)
FB   221.46 (-0.31%)
MSFT   167.75 (+0.39%)
GOOGL   1,483.25 (+0.25%)
AMZN   1,870.54 (+0.31%)
CGC   24.52 (-1.49%)
NVDA   248.94 (-0.14%)
BABA   221.92 (-2.42%)
MU   58.64 (+1.70%)
GE   11.73 (-0.76%)
TSLA   542.98 (+6.36%)
AMD   51.20 (+0.53%)
T   38.53 (+0.39%)
ACB   2.04 (-4.23%)
F   9.18 (+0.22%)
NFLX   336.41 (-0.96%)
BAC   34.52 (-0.58%)
GILD   62.78 (-0.32%)
DIS   143.83 (-0.35%)
S&P 500   3,329.64 (+0.00%)
DOW   29,335.00 (-0.04%)
QQQ   223.70 (+0.14%)
FB   221.46 (-0.31%)
MSFT   167.75 (+0.39%)
GOOGL   1,483.25 (+0.25%)
AMZN   1,870.54 (+0.31%)
CGC   24.52 (-1.49%)
NVDA   248.94 (-0.14%)
BABA   221.92 (-2.42%)
MU   58.64 (+1.70%)
GE   11.73 (-0.76%)
TSLA   542.98 (+6.36%)
AMD   51.20 (+0.53%)
T   38.53 (+0.39%)
ACB   2.04 (-4.23%)
F   9.18 (+0.22%)
NFLX   336.41 (-0.96%)
BAC   34.52 (-0.58%)
GILD   62.78 (-0.32%)
DIS   143.83 (-0.35%)
S&P 500   3,329.64 (+0.00%)
DOW   29,335.00 (-0.04%)
QQQ   223.70 (+0.14%)
FB   221.46 (-0.31%)
MSFT   167.75 (+0.39%)
GOOGL   1,483.25 (+0.25%)
AMZN   1,870.54 (+0.31%)
CGC   24.52 (-1.49%)
NVDA   248.94 (-0.14%)
BABA   221.92 (-2.42%)
MU   58.64 (+1.70%)
GE   11.73 (-0.76%)
TSLA   542.98 (+6.36%)
AMD   51.20 (+0.53%)
T   38.53 (+0.39%)
ACB   2.04 (-4.23%)
F   9.18 (+0.22%)
NFLX   336.41 (-0.96%)
BAC   34.52 (-0.58%)
GILD   62.78 (-0.32%)
DIS   143.83 (-0.35%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Novartis Dividend Yield, History & Payout Ratio (NYSE:NVS)

$95.81
-0.12 (-0.13 %)
(As of 01/21/2020 12:38 PM ET)
Today's Range
$95.65
Now: $95.81
$95.96
50-Day Range
$90.63
MA: $93.99
$95.93
52-Week Range
$74.70
Now: $95.81
$96.06
Volume74,415 shs
Average Volume1.08 million shs
Market Capitalization$219.58 billion
P/E Ratio18.90
Dividend Yield1.92%
Beta0.59

Dividends

Novartis (NYSE:NVS) Dividend Information

Novartis pays an annual dividend of $1.84 per share, with a dividend yield of 1.92%. NVS's most recent annually dividend payment was made to shareholders of record on Wednesday, March 13. The company has grown its dividend for the last 1 consecutive years and is increasing its dividend by an average of -12.16% each year. Novartis pays out 36.15% of its earnings out as a dividend.
Most Recent Dividend:3/13/2019
Annual Dividend:$1.84
Dividend Yield:1.92%
Dividend Growth:-12.16% (3 Year Average)
Payout Ratio(s):36.15% (Trailing 12 Months of Earnings)
35.18% (Based on This Year's Estimates)
32.45% (Based on Next Year's Estimates)
22.60% (Based on Cash Flow)
Track Record:1 Years of Consecutive Dividend Growth
Frequency:Annually Dividend
Most-Recent Increase:$0.5376 increase on 1/31/2019

Dividend Payments by Month (or Quarter)


(Ad)


A brand-new technology - code named "Halo-Fi" - could kill off your overpriced cable company for good... beaming lightning-fast internet to your home for an estimated $7 a month.

This is undoubtedly the beginning of the end for "Big 3" internet providers.

Forward-thinking investors in Halo-Fi are lining up to get rich before January 30th.

Novartis (NYSE:NVS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/31/2019annual$2.86463.27%3/4/20193/5/20193/13/2019
1/27/2017Annual$2.32703/1/20173/3/20173/3/2017
2/1/2016Annual$2.342/24/20162/26/20162/26/2016
2/4/2014annual$2.71863.48%2/27/20143/3/20143/11/2014
2/11/2013annual$2.533.71%2/26/20132/28/20134/5/2013
(Data available from 1/1/2013 forward)
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel